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trauma severity score was calculated for each patient to predict mortality
based on severity of injury and degree of physiologic derangement on
presentation.
Nine patients were treated with the Gore TAG stent graft (W. L. Gore
and Associates, Flagstaff, Ariz), and 17 underwent repair using proximal
extension cuffs from the Excluder AAA endoprosthesis. Excluder devices
were used in patients with aortic diameters 26 cm. Patients treated with
conventional open repair had left thoracotomy with single-lung ventilation
and left-heart bypass. Two patients treated with endografting required
additional procedures, one for type I endoleak and one for delayed graft
collapse, with the latter requiring open operation and graft retrieval and
interposition graft placement. Six patients underwent coverage of the left
subclavian artery during endograft placement, with no adverse sequelae.
Patients treated with endografting had significantly shorter lengths of
stay, less intraoperative blood loss, decreased 24 hour blood transfusion
requirements, and a lower incidence of postoperative tracheostomies com-
pared with patients undergoing open repair of thoracic aortic injuries. There
was no difference in survival between the two groups.
Comment: Despite off-label use and the occasional dramatic compli-
cation of endograft collapse, thoracic stent grafting has rapidly emerged as
standard of care for patients with blunt thoracic aortic trauma. Unlike
patients generally treated for degenerative aneurysms, patients with blunt
thoracic aortic trauma are comparatively much younger. Their aortas will
elongate and dilate as they age. The fate of these grafts over the very long
termwill therefore be very interesting to observe. Given the demographics of
much of the trauma population, I wonder how many of these patients are
actually returning for follow-up examinations? Follow-up in this study was
rather limited. No data were presented beyond hospital discharge.
Ovarian Vein Incompetence: A Potential Cause of Chronic Pelvic Pain
in Women
TropeanoG,Di Stasi C, Amoroso S, et al. Eur J Obstet Gynecol Reprod Biol
2008;139:215-21.
Conclusion: Ovarian vein incompetence is a cause of chronic pelvic
pain in women and responds to ovarian vein sclerotherapy.
Summary: For many years investigators have suggested pelvic varices
can be responsible for otherwise unexplained pelvic pain. Venographic
studies have demonstrated dilation of major pelvic veins with congestion of
the ovarian plexus and broad ligaments in a high percentage of women with
chronic pelvic pain and normal laparoscopy. It appears retrograde flow in
incompetent ovarian veins may be the primary mechanism for dilation of
pelvic veins and congestion of surrounding tissues leading to chronic pelvic
pain. The clinical utility of ovarian vein occlusion and the treatment of such
women are controversial.
The authors evaluated 22 women with laparoscopy aged 19-50 years
who had chronic pelvic pain and no recognized pelvic pathology. All did
have evidence of reflux and dilated pelvic veins on transvaginal color Doppler
ultrasound and subsequently underwent retrograde ovarian vein venography
and sclerotherapy of incompetent ovarian veins. Outcomes were assessed by
a symptom questionnaire and visual analog pain scales at 3, 6, and 12
months. Serial ultrasound examinations were used to evaluate changes in
pelvic circulation after sclerotherapy.
Venography showed 20 of the 22 women had incompetent ovarian
veins, and they subsequently received sclerotherapy, which was not associ-
ated with immediate or late complications. Symptom improvement of
varying magnitude was observed in 85% of the 20 treated women at a mean
follow-up of 12 months. Marked or complete relief occurred in 15 patients
and mild to moderate relief in two patients, with three women (15%) having
no improvement in symptoms. Median visual analog pain scales at 3, 6, and
12months were significantly lower than at baseline: 2.0, 2.5, and 3.0 at 3, 6,
and 12 months vs 8.0 at baseline (P  .001). Follow-up ultrasound
examinations demonstrated recurrence of venous reflux in three patients at 3
months.
Comment: All the women in this study underwent laparoscopy. In
fewer than half were pelvic varices detected by laparoscopy, indicating the
absence of pelvic varicosities at laparoscopy does not rule out the diagnosis.
Ovarian vein reflux as a cause of so-called pelvic congestion syndrome will
remain controversial. The data do suggest, in patients who have had a
thorough history, clinical evaluation, and negative results on standard diag-
nostic tests, that ovarian venography should be considered with the idea of
possibly treating underlying ovarian vein reflux.
Preoperative Shower Revisited: Can High Topical Antiseptic Levels be
Achieved on the Skin Surface Before Surgical Admission?
Edmiston CE Jr, Krepel CJ, Seabrooke GR, et al. J Am Coll Surg 2008;207:
233-9.Conclusion: It is possible to achieve effective decolonization of the
skin before hospital admission in surgical patients.Summary: A recent controversial review from the Cochrane Collabo-
ration suggested evidenced-based data do not support the use of preopera-
tive baths or showers with aseptic agents to reduce surgical site infections in
patients undergoing a surgical procedure (Webster J, Osborne S. Preopera-
tive bathing or showering with skin antiseptics to prevent surgical site
infection. Cochrane Database Syst Rev 2007:CD 004985).
In this study, the authors sought to determine the effectiveness of
chlorhexidine gluconate (CHG) skin concentrations after preoperative
showering/skin cleansing. Two strategies were used to administer the CHG.
Patients used either (A) 4% CHG soap or (B) 2% CHG-impregnated
polyester cloths. There were three shower group strategies used, with 20
subjects per group; each group was divided into 4% CHG soap or 2%
CHG-impregnated polyester cloths. Group 1 A/B patients had evening
showering or skin cleansing, group 2 A/B patients had morning showering
or skin cleansing, and group 3 A/B patients had evening and morning
showering or skin cleansing. After showering or skin cleansing, CHG skin
surface concentrations were determined at five separate skin sites. CHG
concentrations were then compared with CHG minimal inhibitory concen-
trations that inhibited 90% (MIC90) of staphylococcal isolates.
The CHG MIC90 for 61 skin isolates was 4.8 parts per million (ppm).
CHG skin concentrations in the various groups were as follows: group 1A,
17.2 to 31.6 ppm; group 1B, 361.5 to 589.5 ppm (P  .001); group 2A,
51.6 to 119.6 ppm; group 2B, 848.1 to 1049.6 ppm (P .0001); group 3A,
101.4 to 149.4 ppm; and group 3B, 1484.6 to 2031.3 ppm. In subjects
treated with strategy A, effective CHG levels were not detected at selected
sites in 35% of subjects in group 1A, in 15% of subjects in group 2A, and in
25% of subjects in group 3A. There were no subjects who used the 2% CHG
impregnated polyester cloth (strategy B) with skin sites without detectable
CHG levels.
Comment: The Cochrane Collaborative appropriately pointed out the
gap between preoperative skin antisepsis and evidence-based outcomes to
reduce surgical site infection. We still do not know the effect of a carefully
administered preoperative program of skin decolonization on actual reduc-
tion in surgical site infection. As in this study, the surrogate end point of
CHG concentrations does not reflect the clinical end point of surgical site
infection. In addition, none of the volunteers in this study had a body mass
index 40. Comorbidities such as diabetes, renal failure, and nutritional
status that may affect surgical site infection were not assessed. Nevertheless,
it does appear possible to achieve CHG concentrations in the skin that
considerably exceed the MIC90 for staphylococcal isolates. Therefore, al-
though the data are not perfect, there seems little downside in the use of
preoperative antiseptic shower or skin cleansing and it appears that a 2%
CHG-impregnated polyester cloth is superior to 4% CHG soap in achieving
effective MICs on the skin.
Renal Stenting for Incidentally Discovered Renal Artery Stenosis: Is
There Any Outcome Benefit?
Suliman A, Imhoff L, Greenberg JI, et al. Ann Vasc Surg 2008;22:525-33.
Conclusion: Stenting of incidentally discovered renal artery stenoses at
the time of an angiogram performed for another indicated procedure results
in minimal benefit compared with medical management alone.
Summary: Significant renal artery stenosis is frequently encountered at
the time of angiography performed for other forms of arterial disease. The
authors performed a retrospective medical record review of patients under-
going renal arteriography during 4 years. They used catheterization reports
to identify patient diagnosed with high-grade renal artery stenosis (70%).
Patients treated with renal artery angioplasty were identified, and baseline
and postprocedural blood pressure, glomerular filtration rate, serum creati-
nine, and antihypertensive medication regimens were compared after 12
months of follow-up.
During the 4-year period, 124 patients underwent renal arteriography
with 78 (63%) diagnosed with high-grade renal artery stenosis. Renal artery
stents were placed in 58 patients (74%). When compared with the patients
with high-grade renal artery stenosis who received no intervention, the
patients with renal artery stents had similar baseline characteristics with the
exception of lower diastolic blood pressure (74  11.2 vs 80  14.2 mm
Hg, P  .04) and a higher proportion of increased lipids (78% vs 55%, P 
.05). Follow-up was available in 58 of the renal artery stented patients (66%).
Postprocedural variables in patients with renal artery stents with 12-month
follow-up indicated there was reduction in systolic blood pressure (153 
20.8 vs 136  27.2, P  .01) and mean arterial pressure (103  11.2 vs
95  14 mm Hg, P  .04). Significant reductions in systolic mean arterial
and diastolic blood pressure were, however, only noted in the patients who
also had an increase in the number of antihypertensive medications. There
were no differences in renal insufficiency detected.
Comment: This is a retrospective study with incomplete data. Never-
theless, it is certainly not a testimonial to the efficacy of renal artery stents in
patients with unsuspected renal artery stenosis. The only parameter that
improved in the stented patients was blood pressure, and that only improved
if there was an increase in antihypertensive medications. The data do not
support routine practice of renal angioplasty and stenting for incidentally
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artery stenosis remains controversial.
Symptomatic Peripheral Arterial Disease in Women: Nontraditional
Biomarkers of Elevated Risk
Pradhan AD, Shrivastava S, Cook NR, et al. Circulation 2008;117:823-31.
Conclusion: Analysis of biomarkers suggests leukocyte recruitment
and endothelial activation play a prominent role in lower extremity arterial
disease.
Summary: The authors point out that in addition to traditional risk
factors for vascular disease, a number of novel biomarkers also may serve as
markers of increased risk for vascular disease. Most investigations of these
novel biomarkers have addressed coronary artery disease. In this study the
authors critically assessed plasma-based factors as predictors of peripheral
arterial disease (PAD) in a cohort of women derived from the Women’s
Health Study, a study of 27,935 United States women professionals aged
45 years without diagnosed vascular disease at baseline. In 100 subjects the
relationship between baseline levels of novel biomarkers and confirmedincident symptomatic PADwas evaluated prospectively. Biomarkers assessed
were high-sensitivity C-reactive protein, fibrinogen, soluble intercellular
adhesion molecule-1 (sICAM-1), homocysteine, lipoprotein(a), hemoglo-
bin A1c, creatinine, and conventional lipid levels. After multivariable risk
adjustments, biomarkers significantly associated with PAD were high sensi-
tivity C-reactive protein (adjusted hazard ratio [HR] extreme tertiles, 2.1;
95% confidence interval [CI], 1.2-3.7), sICAM-1 (adjusted HR, 4.0; 95%
CI, 1.9-8.6), high-density lipoprotein (HDL) cholesterol (adjusted HR,
0.4; 95% CI, 0.3-0.8), and total cholesterol:HDL-C (adjustedHR, 2.2; 95%
CI, 1.2-3.9).
Comment: This was the first prospective study to evaluate biomarkers
reflective of subclinical inflammation or endothelial dysfunction against
other risk factors for PAD, such as renal dysfunction, conventional lipid
levels, and dysglycemia. The biomarker with the strongest association with
PAD was sICAM-1. This is a proinflammatory adhesion molecule reflecting
leukocyte recruitment and endothelial activation. The authors astutely point
out that factors leading to more gradual encroachment of luminal vessels in
PAD may differ from those leading to the sudden plaque rupture so
important in coronary artery disease associated events.
